Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,431,475 shares of the company’s stock, valued at approximately $8,689,000. Connor Clark & Lunn Investment Management Ltd. owned 0.66% of Enovix at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Enovix in the fourth quarter valued at about $30,000. Parallel Advisors LLC grew its holdings in shares of Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares during the last quarter. CWM LLC grew its holdings in shares of Enovix by 95.4% during the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after buying an additional 2,969 shares during the last quarter. Calamos Advisors LLC acquired a new position in Enovix in the 1st quarter valued at about $60,000. Finally, Gateway Wealth Partners LLC acquired a new position in Enovix in the 1st quarter valued at about $68,000. 50.92% of the stock is owned by hedge funds and other institutional investors.
Enovix Price Performance
Enovix stock opened at $3.40 on Thursday. Enovix Corporation has a one year low of $3.06 and a one year high of $14.21. The company has a debt-to-equity ratio of 2.46, a quick ratio of 9.37 and a current ratio of 9.71. The business has a fifty day moving average of $4.79 and a two-hundred day moving average of $5.67. The company has a market cap of $746.13 million, a P/E ratio of -4.20 and a beta of 2.32.
Wall Street Analyst Weigh In
A number of analysts have weighed in on ENVX shares. Bank of America reaffirmed a “neutral” rating and set a $5.00 price objective on shares of Enovix in a research report on Monday, August 17th. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. William Blair cut shares of Enovix from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Benchmark lowered their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Finally, Loop Capital upgraded shares of Enovix to a “strong-buy” rating in a research note on Monday, August 17th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.77.
View Our Latest Research Report on Enovix
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Recommended Stories
- Five stocks we like better than Enovix
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
